Centessa Pharmaceuticals plc (NASDAQ:CNTA) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eight research firms that are currently covering the stock, MarketBeat reports. Two analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 12-month target […]

Leave a Reply

Your email address will not be published.

Previous post Pinterest, Inc. (NYSE:PINS) Receives $34.86 Average Target Price from Brokerages
Next post EastGroup Properties (NYSE:EGP) versus Mapletree Industrial Trust (OTCMKTS:MAPIF) Financial Comparison